Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.37 Analyst target: $2.15 Upside: 473.95%
Evogene Ltd., is a computational biology company. The company is headquartered in Rehovot, Israel.
See the full interactive analysis & chart →Informational only — not investment advice.